Herd immunity

High COVID-19 Vaccine Uptake Proving Critical for Achieving Individual and Population Immunity

Retrieved on: 
Tuesday, February 2, 2021

Early reports indicated that such antibodies decline substantially over less than six months, raising questions about how long protective immunity might last following infection.

Key Points: 
  • Early reports indicated that such antibodies decline substantially over less than six months, raising questions about how long protective immunity might last following infection.
  • T cells are also known to be important in protecting against many viral infections through processes known as cellular immunity.
  • "The study concluded: "High vaccine uptake will be critical to achieving individual and population immunity.
  • Open debate and public education campaigns will be required to build trust and counter vaccine hesitancyand effective pharmacovigilancewill be needed to monitor long term safety.

High COVID-19 Vaccine Uptake Proving Critical for Achieving Individual and Population Immunity

Retrieved on: 
Tuesday, February 2, 2021

Early reports indicated that such antibodies decline substantially over less than six months, raising questions about how long protective immunity might last following infection.

Key Points: 
  • Early reports indicated that such antibodies decline substantially over less than six months, raising questions about how long protective immunity might last following infection.
  • T cells are also known to be important in protecting against many viral infections through processes known as cellular immunity.
  • "The study concluded: "High vaccine uptake will be critical to achieving individual and population immunity.
  • Open debate and public education campaigns will be required to build trust and counter vaccine hesitancyand effective pharmacovigilancewill be needed to monitor long term safety.

1.7 million doses of COVID-19 vaccine needed to achieve herd immunity in Travis County, Texas

Retrieved on: 
Friday, January 29, 2021

Austin, Texas, Jan. 29, 2021 (GLOBE NEWSWIRE) -- About 1.7 million doses of COVID-19 vaccine will need to be administered for Travis County to reach a herd immunity level of 67 percent, according to research released by Sendero Health Plans.

Key Points: 
  • Austin, Texas, Jan. 29, 2021 (GLOBE NEWSWIRE) -- About 1.7 million doses of COVID-19 vaccine will need to be administered for Travis County to reach a herd immunity level of 67 percent, according to research released by Sendero Health Plans.
  • We estimate that to administer 1.7 million doses over the course of 26 weeks, 65,000 doses will need to be administered weekly.
  • To reach herd immunity in Travis County, 67 percent coverage is needed more than two times over what was achieved ten years ago.
  • Moreover, when compared to the H1N1 vaccination effort, 1 million more doses of the COVID-19 vaccine will need to be administered.

Welltok Stresses Importance of Personalized COVID-19 Vaccine Outreach in New Survey Report

Retrieved on: 
Tuesday, January 19, 2021

To achieve herd immunity will require getting the 'moveable middle' to take action," said April Gill, chief strategy officer for Welltok.

Key Points: 
  • To achieve herd immunity will require getting the 'moveable middle' to take action," said April Gill, chief strategy officer for Welltok.
  • "We are leveraging healthcare and non-healthcare data to predict who may be on the fence about getting the vaccine and why to develop and deliver fact-based, personalized messages to overcome vaccine hesitancy."
  • Toget a pulse on the general population's perceptions about the COVID-19 vaccines, Welltok partnered with research firm Ipsos to conduct a nationwide survey.
  • Get the full survey findings and learn more by downloading This Is Your Shot: Get Your COVID-19 Vaccine Communications Right here .

Arcadia Prepares Healthcare Organizations for COVID-19 Vaccination Outreach: 'The Single Greatest Patient Engagement Challenge of Our Lives'

Retrieved on: 
Tuesday, January 5, 2021

And in 2021, the Arcadia Analytics platform will help Arcadia's healthcare customers achieve COVID-19 herd immunity for the populations they serve.

Key Points: 
  • And in 2021, the Arcadia Analytics platform will help Arcadia's healthcare customers achieve COVID-19 herd immunity for the populations they serve.
  • "The healthcare community faces the single greatest patient engagement challenge of our lives," said Arcadia chief medical officer Rich Parker, MD.
  • "Healthcare organizations need two major analytics-driven capabilities to support COVID-19 vaccination," explained Arcadia vice president of customer success Anna Basevich.
  • Arcadia (arcadia.io) is the only healthcare data and software company dedicated to healthcare organizations achieving financial success in value-based care.

Hong Kong Father and Daughter Team Work Together to Bring Patented MONOmask.5c to Market

Retrieved on: 
Wednesday, December 30, 2020

HONG KONG, Dec. 30, 2020 /PRNewswire/ -- Even as COVID-19 vaccines are being administered to millions, new cases are spiking across the country.

Key Points: 
  • HONG KONG, Dec. 30, 2020 /PRNewswire/ -- Even as COVID-19 vaccines are being administered to millions, new cases are spiking across the country.
  • Considering the current statistics and the new coronavirus strain, the fact remains wearing a mask will remain a reality for quite some time.
  • Some experts predict mandatory masks will be necessary for the next 9-12 months until herd immunity kicks in.
  • Moreover, the MONOmask is made ofrecyclable materials and not stopping there, only the filter is required to be changed daily.

ReturnSafe Raises $3.25M To Accelerate Adoption Of New Workplace Safety And Infectious Disease Management Solution

Retrieved on: 
Tuesday, December 22, 2020

ReturnSafe is not only helping companies keep their employees safe from COVID-19, it is setting new standards to prevent future disease outbreaks in the workplace."

Key Points: 
  • ReturnSafe is not only helping companies keep their employees safe from COVID-19, it is setting new standards to prevent future disease outbreaks in the workplace."
  • ReturnSafe's infectious disease management platform has established a new paradigm for safety, health, and well-being by offering organizations an integrated solution that prevents and slows the spread of infectious diseases.
  • Vaccine management for employersto oversee workplace immunity without compromising on employee safety and privacy, the most recent addition to the platform.
  • With this new funding, we will scale our efforts for infectious disease management with new proactive and reactive capabilities like our vaccine and immunity management."

ReturnSafe's New Vaccine Management Solution Monitors Vaccine Adoption and Manages Mixed Immunity in the Workplace

Retrieved on: 
Thursday, December 17, 2020

AUSTIN, Texas, Dec. 17, 2020 /PRNewswire-PRWeb/ -- ReturnSafe , a mission-driven BioSecurity company focused on workplace health safety, announced today the launch of a new vaccine management solution that helps businesses and organizations manage workplace immunity, enabling a safe reopening during the coronavirus pandemic.

Key Points: 
  • AUSTIN, Texas, Dec. 17, 2020 /PRNewswire-PRWeb/ -- ReturnSafe , a mission-driven BioSecurity company focused on workplace health safety, announced today the launch of a new vaccine management solution that helps businesses and organizations manage workplace immunity, enabling a safe reopening during the coronavirus pandemic.
  • A solution to help manage these diverse populations is critical," said Tarun Nimmagadda, founder and chief executive officer at ReturnSafe.
  • approved COVID-19 vaccination and two more coming soon, ReturnSafe's vaccine management tool enables employers to manage workplace immunity by tracking type and date.
  • By providing real-time insights and metrics on vaccine adoption amongst the workforce, employers can identify when workplace vaccination advocacy campaigns need to be implemented, a key program to successfully achieving herd immunity.

How To Convince The Public To Participate In Covid Vaccine Program

Retrieved on: 
Tuesday, December 15, 2020

In order to achieve herd immunity, the United States will need 70% to 80% of the population vaccinated against Covid 19.

Key Points: 
  • In order to achieve herd immunity, the United States will need 70% to 80% of the population vaccinated against Covid 19.
  • "The fundamental issue is a marketing problem, one that boils down to perception and behavior," said Dr. David Bridwell.
  • "Modern understanding of changes in perception and behavior can actually be informed by what we know about marketing.
  • In other words, we can understand how individuals go about making major life decisions using principles from marketing psychology."

New Campaign Encourages All to "Keep Up The Rates" and Get Vaccinated Amidst COVID-19

Retrieved on: 
Tuesday, August 18, 2020

The campaign, led by the National Foundation for Infectious Diseases (NFID), encourages all individuals to receive recommended vaccines that may have been delayed in recent months as the country responds to COVID-19.

Key Points: 
  • The campaign, led by the National Foundation for Infectious Diseases (NFID), encourages all individuals to receive recommended vaccines that may have been delayed in recent months as the country responds to COVID-19.
  • "Unfortunately, it's impossible to get vaccinated from the comfort of your own couch.
  • As a result, we have seen a troubling drop in routine immunization rates across all age groups in the US.
  • Individuals who are not able to get vaccinated due to underlying health conditions rely on community immunity to protect them.